首页> 美国卫生研究院文献>Journal of Clinical Microbiology >Serial Testing from a 3-Day Collection Period by Use of the Bartonella Alphaproteobacteria Growth Medium Platform May Enhance the Sensitivity of Bartonella Species Detection in Bacteremic Human Patients
【2h】

Serial Testing from a 3-Day Collection Period by Use of the Bartonella Alphaproteobacteria Growth Medium Platform May Enhance the Sensitivity of Bartonella Species Detection in Bacteremic Human Patients

机译:通过使用Bartonellaαproteobacteria细菌生长培养基平台从3天收集期进行的系列测试可能会增强细菌性人类患者中Bartonella物种检测的敏感性。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Patients with infection from bacteremic Bartonella spp., tested using Bartonella Alphaproteobacteria growth medium (BAPGM), were retrospectively categorized into one of two groups that included those whose blood was collected once (group 1; n = 55) or three times (group 2; n = 36) within a 1-week period. Overall, 19 patients (20.8%) were PCR positive for one or more Bartonella spp. using the BAPGM platform. Seven patients (12.7%) in group 1 tested positive, and 12 patients (33.3%) in group 2 tested positive. Detection was improved when the patients were tested three times within a 1-week period (odds ratio, 3.4 [95% confidence interval, 1.2 to 9.8]; P = 0.02). Obtaining three sequential blood samples during a 1-week period should be considered a diagnostic approach when bartonellosis is suspected.
机译:使用Bartonella Alphaproteobacteria生长培养基(BAPGM)测试的细菌性Bartonella spp。感染患者被回顾性分为两组,其中一组血液收集一次(组1; n = 55)或三组(组2; n = 36)在1周内。总体而言,有19例(20.8%)患者的一种或多种Bartonella spp PCR阳性。使用BAPGM平台。第一组的7名患者(12.7%)检测为阳性,第二组的12名患者(33.3%)检测为阳性。在1周内对患者进行了3次测试,检出率得到了改善(赔率,3.4 [95%置信区间,1.2至9.8]; P = 0.02)。如果怀疑存在巴氏杆菌病,则在1周内连续采集三个血样应被视为一种诊断方法。

著录项

相似文献

  • 外文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号